Julie D. Klapstein

Julie D. Klapstein, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Amedisys Inc, Claritev Corp and Nextgen Healthcare, Inc. Between 1 May 2016 and 5 October 2026, the trades on record add up to 43 filings.

On the open market, the record shows 2 purchases worth €104k and 5 sales worth €77k. Netting one side against the other leaves €27k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 33 share grants.

On 7 October 2026 came the latest disclosure, a share grant in Omada Health, Inc. The clock since the last published purchase (23 August 2021) now reads 1,888 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.